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Summary.-Delay between initiation and promotion on mouse skin was in 1949
reported by Berenblum and Shubik not to affect tumour yields, and this led to the
important concept of the irreversibility of initiation and stimulated the development
of multistage models. Subsequent reports have, however, suggested that delay does
decrease tumour yields, and this is confirmed by the present study of 2200 mice
initiated at 8, 48, or 68 weeks with 10, 30, 100, or 300 ,ug of DMBA and promoted by a
standard dose of TPA for 15 weeks, after various delays. However, our data suggest
that the decrease in tumour yields is chiefly or wholly due to a reduction, among
ageing mice, of the ability to respond to promoters, and not to any substantial loss of
initiated cells, for late initiation with immediate promotion also yielded a less rapid
response than early initiation with immediate promotion. Interpretation of all such
studies is complicated by the few weeks that the skin needs to repair ulceration and
other damage induced by the higher doses of DMBA, for if promotion with TPA
begins before such repair is complete the tumouryield maybe misleadingly increased.
Time between initiation andpromotion.-
When mouse skin is "initiated" with a
single dose of DMBA (7,12-dimethyl
benz(a)anthracene) and is then "pro-
moted" with regular treatment for several
weeks or months with croton oil or an
active extract of it (Hecker, 1971) such
as the phorbol ester TPA (12-0-tetra-
decanoyl-phorbol-13-acetate), it is well
known that "papillomas" will arise. How-
ever, there are conflicting claims (see
below) in the literature as to whether the
quantitative response to this combination
of treatments is the same if mice initiated
at age 6-10 weeks are kept after initiation
for several months before promotion
begins.
Dose of initiator per unit area.-If
the local concentration of initiator on
mouse skin is large enough to cause ulcera-
tion or skin erosion or inflammation, then
this complicates the experimental outcome
since
(i) skin healing after either mild or
severe ulceration has sufficient promoting
action§ to cause some papillomas to arise
without any external promotion, and
(ii) ulceration severe enough to remove
the basal layer completely will remove
some of the initiated cells that are to be
studied, and it is unclear what proportion
of initiated basal cells can be expected in
the subsequent epithelial regrowth over a
severely ulcerated area.
* Requests for reprints to: Department of Pathology, University of Oulu, SF 90220, Oulu 22, Finland.
t Imperial Cancer Research Fund Reader in Cancer Studies, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford OX2 6HE.
t Imperial Cancer Research Fund Cancer Epidemiology & Clinical Trials Unit, Oxford OXI 3QG.
§ Healing appears to have promotional effects lacked by simple irritation (Tomatis et al., 1962) or
hyperplasia (Raick, 1974).
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The likelihood of ulceration depends, of
course, not only on the strain of mouse
and the dose of initiator, but also on the
volume and physical nature of the vehicle
in which the initiator is applied. Some
experiments have used 0-2 ml of acetone,
which spreads the initiator over the whole
shaved back of the mouse and reduces the
likelihood of ulceration, while others have
used only about 0 02 ml of liquid paraffin,
which confines the initiator to an area
less than 0-5 cm2 between the shoulder
blades of the mouse. This has the advan-
tage ofpreventing the animal from scratch-
ing the treated area, but at the expense
of increasing the likelihood of ulceration.
Previous experiments.-Berenblum &
Shubik (1949) studied female Swiss mice,
the shaved backs of which were initiated
with "a drop on the end of a fine glass
rod" of a 15% solution of DMBA in
liquid paraffin. If the volume deposited
was about 0 02 ml, each mouse must have
received about 300 [kg of DMBA in a small
region of the back. These mice were later
promoted for 17 weeks with regular croton
oil. In one experiment, 100 mice underwent
promotion "early" (Weeks 3-20 after
initiation), while in another experiment
25 mice underwent promotion "late"
(Weeks 43-60 after initiation). In both the
"early" and the "late" experimenits,
there was almost nointercurrent mortality,
and about halfthe mice developed at least
one papilloma, while half developed no
papillomas. This apparent similarity of
response of the animals promoted during
Weeks 3-20 and 43-60 after initiation has
generally been taken as evidence that
initiation is essentially irreversible, a
conclusion which has acted as animportant
stimulus to the fruitful development of
''multistage models" for cancer induction
(e.g. Armitage & Doll, 1961; for review,
see Peto, 1977, or XVhittemore & Keller,
1978).
Unfortunately, subsequent work has
not confirmed the evidence* on which this
conclusion rests, and delay between initia-
tion and promotion does appear to
decrease the response to the promoter
(Roe & Salaman, 1954; Roe et al., 1972;
van Duuren et al., 1963, 1967, 1975,
1978; Hieger, 1965). However, this does
not necessarily imply any progressive
loss of initiated cells, as (a) the biological
potency of promoters in ageing mouse
skin may be less than in the skin of young
adult mice, and (b) promotion during the
few weeks while the skin is recovering
from the ulcers, erosions and other less
obvious short-term effects of initiation
may cause more papillomas to become
visible than would promotion after the
skin had repaired itself. Explanations (a)
and (b) could account for the observation
by van Duuren et al. (1978) of
(a) earlier response to early initiation
with immediate promotion than to late
initiation with immediate promotion, and
(b) nmore papillomas with late initiation
and late (i.e. immediate) promotion than
with early initiation and late promotion.
The present study extends the results of
van Dtiuren et al. (1978) in various ways.
METHODS
WVe have studied initiation Mwith both
ulcerating and non-ulcerating doses of
DMBA at 8, 48, or 68 weeks of age, followed
by promotion with TPA at various subse-
quent ages (Fig. 1 and Table). These compari-
sons allow 3 main questions to be addressed:
(i) w%Nhether initiated cells appear to persist,
* One unexplainiedl pectlliarity of the 1949 reuilts is that the tumour yield aInd mortality wvere so lo-w,
tlhouglh severe ulceration (sometimes fatal) an(i multiplel papillomas usually dlevelop in IrespoInse to such
treatment with DMIBA. Indeed, in previoois stud(ties by the same authtors (Berenblum & Sliubik, 1947a,b)
these same treatments catused many ear-ly (leatlis and produced papillomas amonig almost all tlhat, (lid not die.
Moreover, Roe et al. (1972) obtained an average of 8 ttumours per Swiss moluse by applying only 100 ,ug of
DMBA (albeit in 0-2 ml acetone) before promotion. Lacking any obx-ious explanatioin, the possibility of
teclnical error by Berenblum & Sliuibik (1949) cannot be excluldedl, buit of couirse some genetic or other
peculiarity of these particuLlar animals or experimental conditions (e.g. a tlickened skin (ltue to the ecto-
parasites whieb affected most laboratory mice in those (lays) may explain tlhe anomaly, especially since
outbred mice have been slhown to be genietically extremely heterogeneous xwith respe(t to 2-stage carcino-
genesis (Bouitwell. 1964).
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TABLE.-Numrbers of mice initiated on each treatment schedule
Age at
initiation
Protocol (wks)
a 8
b 8
c 8
(1 8
e 8
f 48
g 48
Ii 68
i 8
Total (all protocols)
Age
(lurin1g
promotion
(x lks)
11-26
18-33
31-46
51-66
71-86
51-66
71-86
71-86
(spare)
Initiating (lose of l)ABA
(KLg)
300 100 30 10
80 40 40 40
80 40 40 40
80 40 40 40
60 60 60 60
80 80 80 80
60* 60* 60* 60*
80* 80* 80* 80*
80* 80* 80* 80*
40 40 40 40
640 520 520 520
* SomewhItat larger l-ttinberis of 8-+vceek-old mice bia(l to be obtained and kept tuntreate(l for 40 or 60 weeks
for these niumbers of survivors to be available foi initiation at 48 or 68 weeks.
(ii) whether the promotional effects of TPA
decrease writh age, and (iii) the relationship
b)etween the dose of DMBA and the response
to a standard course of treatmeiit with TPA.
To make our results more manageable, wN-e
have presented and discussed the parts of
our data which bear on these 3 distinct
questions in 3 separate, though overlapping,
papers. Moreover, for simplicity of presenta-
tion we have summarized our principal
results graphically, relegating the detail of
the data from which these graphs, derive to
reduced-size tabular appendices.* After the
description of our experimental and statistical
methods, this first paper will address itself
to the question ofthe persistence ofinitiation.
Test animals. Female Swviss mice, randolm
bred at the Eppley Institute, were used, and
were 8 weeks old at the start of the experi-
ment. All animals w,ere randomized before
treatment, and were kept unvaccinated in
groups of 10 in plastic cages ith a wrire mesh
top in Sanicel bedding, and given WVaynie
pelleted diet (Wayne Corp., South Bend,
Ind.) and wrater ad libitum,. The animals wiere
allowed to die spontaneously or were killed
when moribund, and we then attempted to
determine wNhether skin tumours had, directly
or indirectly, caused that death; in almost
all cases, an unequivocal answer was obvious.
Chemicals. DMBA w,as ol)tained from
Aldrich Corp., Milwaukee. Wis., and purified
and analysed by paper chromatography for
purity (which wNas alw,ays more than 990o).
DMBA solutions in acetone were always pre-
pared immediately before use and were
checked quantitatively before use; no dis-
crepancies were found. The tumour promoter
12-0-tetradecanoyl-phorbol-13-acetate (TPA)
was obtained from Midland Corp., New York,
N.Y., and checked for purity before use, as
well as regularly during treatment, by the
mnethod of Roe et al. (1972). Acetone solutions
were prepared monthly and all batches were
checked quantitatively both before and after
use; again, no discrepancies were found.
Fluorescence-free acetone solvent (Fisher
Co., Chicago, Ill.) was used.
Treatment.-The chemicals were applied to
the small interscapular region of the back
(an area which cannot be scratched by the
animals) with a precision pipette (Hamilton
Ind., London, Ont.) 0-017 ml at a time. An
area of about 1 cm2 of the interscapular
dorsal skin was regularly shaved with an
electrical clipper, care being taken not to
erode the skin. The part of this area which
wAas actually treated did not have a very sharp
boundary, being defined by the spread of the
0-017 ml of acetone solution which was
applied, but it was roughly circular with a
diameter of about 0 5 cm, and hence with an
area certainly less than 0-5 cm2. In such a
small area, there is not room for many
tumours to develop.
All animals had to be in the resting stage
ofthe hair cycle at the time ofinitiation, since
it is well known that the hair cycle affects the
* In a stu(ly with as maniy groups as thlis, some lhunidre(ds of (different pairwise comparisons between groups
are possible, ancd so all sorts of anomalies cani be expectedi to arise by clhanice. To get reliable answers to our
main questions, we slall tlherefore lhave to average some of ouir groups together in ordler to reduce purely
random erros. Tabulation of the analys;es leading to sucli combinations of groups resuilts in rather a mass of
numbers.
Total
200
200
200
240
320
240
320
320
160
2200
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efficacy of the initiator (Berenblum et al.,
1958; see also Manil et al., 1981). To determine
wArhether animals Aere in resting stage, their
entire backs were shaved, and 1 week later
thev were examined for signs ofregrowth. At
Week 8, animals then in the resting stage were
randomized 5 ways, betweendelayedinitiation
and immediate initiation wNith a particular
one of the 4 DMBA doses, while all animals
not in the resting stage were put into the
"delayed initiation" group. (Because of the
presumed uniformity of the hair cycle in all
animals, it was not felt that the "delayed"
group wA-ould thereby be biased, but w-e have
no direct check on this supposition.) At Week
48 the survivors ofthe "delayed" group which
wN-ere then in the resting stage Awere likewise
randomized 5 wAays, one group plus those not
in the resting stage at Week 48 having
their DMBA initiation further delayed.
At Week 68 all animals were randomized
irrespective of hair cycle, but the treatment
of those undergoing regrowth was delayed
for a week to allow reversion to the resting
stage.
Tumours and other skin lesions-.Animals
were checked weekly and gross appearance,
behaviour, nutritional status, etc., were
recorded. All skin lesions were measured and
charted wNeekly, size and gross appearance
(apparent nature, shape, colour, necrosis,
etc.) beingnoted. Foreachtumourwerecorded,
where relevant, any preceding lesions (e.g.
ulceration or hyperplasia), week of appear-
ance, wNeek of apparent progression from one
type of tumour to another, and wieek of
regression. Particular care was taken to
record accurately the week w,hen a tumour
first attained a maximal diameter of at least
10 mm.
Histology.-A complete necropsy was per-
formed and all grossly visible lesions, diseases,
tumours, etc. were recorded. All skin lesions
and tumours, plus selected specimens from
other organs, were studied histologically.
Formalin-fixed, paraffin-embedded specimens
were sectioned, stained with haematoxylin
and eosin and other stains as needed, and
examined histologically by F. Stenback,
using standard criteria for morphology
(Stenback, 1969). Most skin tumours that
did not regress spontaneously wsrere available
for histological confirmation, since fewr mice
were lost due to decomposition or cannibalism.
Information for lost tumours, for regressing
tumours, and for tumours ultimately con-
fluent with other surrounding lesions is based
upon gross observation, but there wvas never
a case where the fact of malignancy or other-
wise was uncertain.
Survival.-In general, the groups given 10
or 30 [kg DMBA had, at least until w-ell after
the 15-week course ofpromotion was finished,
death rates very similar to the controls which
received no DMBA (about 75O% remaining
alive at 1 year), but the groups receiving 100
or 300 [g ofDMBA suffered much more rapid
mortality, so much so that there wvere too
few of these animals left for proper study of
the effects of a 43- or 63-week delay between
initiation and promotion. Among the mice
receiving 100 or 300 itg of DMBA, inflamma-
tion, reddening and superficial erosion of the
whole of the small treated area were usually
apparent within a few days, and sometimes
thewholeepithelium,includingthe basal layer,
was lost. These early changes gradually dis-
appeared, and the animals then remained
healthy for a month or two, after which, even
without promotion with TPA, some tumours
began to appear. Ultimately, even in the
absence ofpromotion, many animals initiated
wvith 100 or 300 [kg of DMBA developed
severe ulcers with raised borders as well as
various tumours, and several died of these
causes.
Indices of response.-Four separate indices
of neoplastic response have been analysed for
each comparison, usually with concordant
results. (The need for more than one analysis
arises because the difference between an
irreversible, invasive carcinoma and the sort
of transient benign papilloma typically pro-
duced by TPA is so extreme that it could not
necessarily be assumed that their aetiologies
and relationships to treatment would be
similar.)
(i) Number of tumours
We may count the total numbers of
tumours, irrespective of size or type, arising
during the 20 weeks from the beginning of
promotion, on mice alive at the end of that
20-week period. (A 20-week period is long
enough to include most of the papillomas
arising after initiation+ 15 weeks' promotion,
but is not long enough for significant numbers
of deaths from tumours.)
(ii-iv) Tumour-bearing animals
(ii) Among animals which wN-ere tumourless
at the start of a particular period (e.g. at the
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start of promnotion) wve many count the nutn-
bers of animals which ultimnately develop
one or more tumours (i.e. tumours of any size
or type).
(iii) Among animals which were without a
10mm tumour at the start of a particular
period wre may count the number of animals
which eventually developed a 10mm tumour.
(iv) Among animals which were without an
apparently malignant tumour at the start
of a particular period we may count the num-
ber of animnals which eventually developed a
malignant tumour. (Every week it was noted
whether each tumour seemed malignant, so
for histologically malignant tumours we can
use the week of first apparent malignancy.
Statistical nmethods.-For each of the above
4 indices ofresponse, the fundamental concept
underlying the statistical comparison of
tumour yields in a fewA, particular treatment
groups is to contrast the observed numbers of
tumours, 0, in each of these groups with the
"'expected" numbers, E, and to calculate their
ratios, O/E. "Expected" nurnber has the
usual meaning in statistics. That is, if the
tumours in the few particular groups being
statistically compared were shared out among
those groups in proportion to the numbers at
i,sk in them, how many would be expected
in each group: For exarnple, when comparing
the effects of300, 100, 30 and 10 ,ug ofDMBA
followed by immediate promotion on the
total numbers of tumours on survivors at
20 weeks, wve observed respectively 146/73.
49/34, 25/38 and 25/39 (total: 245/184)
tumours/survivors. Since the average rate
is 245/184=1-33 tumours/survivor, we wvould
"expect" 73 x 133=97 2 tumnours on the
73 high-dose survivors if the total of 245
tumours were shared out equally among all
4 groups. In fact, of course, there were more
tumours than average in the high-dose group
(viz. observed = 146, expected =97-2; O/E =
146/97-2 =15) -while in the low-dose group
observed was of course less than expected,
and the four O/E ratios were 1-5, 1F1, 0 5 and
0(5. -which conveniently describes the relative
risks due to different doses.
For the analyses (ii), (iii), and (iv) oftitne to
the first ocurrence of some specified type of
tumour, differences in longevity must be
allowed for -when calculating expected num-
bers (IARC, 1980). Advantages of using Os
and Es include the facts that:
(a) Different comparisons can be pooled
simply by adding up the corresponding Os
and Es: many examples will be found in the
appendices to these 3 papers.
(b) P values for the differences between
groups in respect of numbers of tumour-
bearing animals (although not for the total
numbers oftumours) can be derived from the
differences between Os and Es (as in Peto &
Pike, 1973; for discussion, see IARC, 1980).
(c) The ratios O/E provide a useful descrip-
tion ofthe relative impact ofthe tumour type
of interest on the particular groups being
compared and, when the O/E values for the
4 different indices of response (i-iv) all give a
similar impression, a satisfactory character-
ization ofthe differences between those groups
has been achieved.
A fuller discussion ofthe statistical methods
(ii), (iii), and (iv) that we have used for our
analyses of time-to-tumour may be found in
the annex on statistical methodology for
animal experiments to IARC (1980), the
methods used being those described for
tumours that are observed in a "mortality-
independent" context.
Appendix Table (a) summarizes certain
indices of response to promotion in the 8
groups -which wN,ere scheduled to be promoted.
(Because promotion lasted for 15 weeks only,
the papillomatous response to promotion is
adequately characterized by the tumour yield
within 20 weeks of starting promotion.)
RESULTS
This first paper now deals only with
the persistence of initiation, which was
the main question we wished to study.
Our second paper (Stenback et al., 1981a)
deals with systematic differences between
the effects of giving the same initiating
dose at different ages, followed by the
same interval before promotion. Our third
paper (Stenback et al., 1981b) deals with
the shape of the dose-response curve.
This subdivision helps to make the data
manageable, because most of the analysis
and discussion in Papers II and III is not
relevant to the present question of the
persistence of initiation. However, 2
conclusions from those analyses are needed
here, namely:
(1) Among the groups initiated but not
promoted for some time, healing of the
ulcerations and erosions caused by DMBA
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FIG. 1.-The ages at wlhich initiation (a single dose of DMBA in acetone) and promotion (3-2 ,ug of
TPA in acetone twice weekly for 15 weeks) were performe(l. The schedlules have been lettered a, b,
c, d, e, f, g, l1, i for reference in the text.
alone had a substantial promoting effect,
at least in the 2 higher dose groups
(Figs 3 and 4 in Stenback et al., 198lb).
(2) Either initiation, or promotion, or
both, are less effective at age 18 months
than earlier, for initiation plus immediate
promotion yielded only half as many
tumours at 68-86 weeks as it had done at
8-26 weeks or 48-66 weeks, when the
yields were about equal (Fig. 1 in Stenback
et al., 1981a).
Bearing these conclusions in mind, let
us first examine the observations which
reproduce and extend the original experi-
ment of Berenblum & Shubik (1949). Fig.
2 summarizes the statistical comparison
of Schedules a, b, c, d, and e, in which the
mice were all initiated at age 8 weeks and
then promoted for 15 weeks from ages
11, 18, 31, 51, and 71 weeks, respectively.
(For numerical details, see Appendix
Tables b and c). In Fig. 2 it is apparent
that the tumour yields are not constant
(P=0 0004 for trend), as was also found
by Roe et al. (1972) and by van Duuren
et al. (1978). Immediate promotion yields
more tumours than any other protocol,
perhaps because TPA and wound healing
are synergistic. If this is the true explana-
tion, then in experiments at much lower
dose levels, spread over the entire back
5s _
j,i!U
It' 10 31
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Fi-. 2. Tumour response: O/E values
according to age at the start of promotion
for animals initiated at 8 weeks (from
Appendix Tables b and c). The 4 different
measures of response are all shown, but
950 confidence intervals are indicated
only for 0, for wlich the P Xvalue for trend
is 0 0004. Points based on fewer than 20
tumours are in parentheses.
0 All tumours within 20 weeks. O First
tumours of any size or type. O First 10 mm
tumours. A First malignant tumour.
a
b
c
d
e
f
g
h
i
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and insufficient to cause any erosion or
minor skin changes, there might be no
special synergy with early TPA (unless the
proliferative or other effects of TPA 3
weeks after initiation interfere with some
hypothetical form of slow repair of the
DMBA-induced damage to the DNA in the
stem cells).
What is more interesting, however, is
the apparenit further reduction in response
among animals promoted at 71-86 weeks
of age, as compared with animals treated
at 51-66 weeks or earlier. The magnitude
and timing of this decrease in response at
71-86 weeks is similar to the 50%0 reduc-
tion in response reported in our accom-
panying paper (Fig. 1 in Stenback et al.,
1 981a) when initiation (with promotion
starting 3 weeks later) takes place in
animals aged 68 weeks rather than at
8 or 48 weeks ofage. The grouips ofanimals
concerned in these 2 comparisons (Fig.
2 and ibid., Fig. 1) are with one exception
(Group a) completely different. Thus the
observed decreases in response to promo-
tion at 71-86 weeks in both of these age
relationships are statistically fairly inde-
pendent of each other. However, the fact
that the 95% confidence intervals are
in each case rather wide for the groups
promoted at 71-86 weeks means that
chance factors may have made the 2
relationships appear more similar than
thev wotuld have in an even larger study.*
Despite this reservation, the most
economical explanation for the observed
similarity between these 2 patterns is
that the one factor which is common to
Fig. 2 and ibid., Fig. 1 i.e. promotion at
71-86 weeks rather than earlier, explains
the decrease in effect in both graphs. If it
is provisionally accepted that promotion
at about 18 months of age is about 50%0 less
potent than pronmotion during the first year
or so ofadult life, our data offer no evidence
whatever for any substantial loss of
initiated cells as initiated mice grow older.
1.5
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Fic. 3. Tumour response: O/E values com-
parinig animals iiiitiatecl at age 48 weeks
andt promoted at 51-66 or at 71-86 week-s
(from Appen(ix Tables b andl c). Symbols
as in Fig. 2.
The foregoing conclusions are consistent
with our findings (Fig. 3; for numerical
details, see Appendix Tables b and c that,
among animals initiated at 48 weeks,
promotion at 51-66 weeks produces twice
the tumour inicidence of promotion at
71-86 weeks. The postulated 50%0 decrease
in the efficacy of TPA promotion at 71-86
weeks wouild contribute to the difference
seen in Fig. 3. Another contribution to it
would be provided by our previous postu-
late that, if TPA is given promptly (3
weeks) after DMBA, the net promotional
effect is greater (owing, perhaps, to aggra-
vation of the promotional effects ofwound
healing, or perhaps to interference with
slow DNA repair). Between them, the
hypotheses invoked previously are sup-
ported by, and account naturally for, the
statistically significant difference seen in
Fig. 3.
Thus far we have supposed that the
numbers of initiated cells produced by a
given dose of DMBA does not vary much
with age, and that there is no material
loss of initiated cells as animals age. We
have then inferred that the promotional
* Tlbe approximate stu(ly sizes to date in wlmieb the effects of (lelaying promotbon liav-e beeni studied are
120 (1949), 50 (1954), 30 (1963), 60() (1965), 80 (1967), 310 (1972), 560 (1975/8) andl now 2200 mice (1980).
All tie larger stuclies liave shown a (decrease in response if promotioni is delayed, buit only thie first study,
wbrere no (lecrease was e-idlent, is widely kniown.
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FI(u. 4. Tumour response.: O/E X alues givinl(g
relationships bet-ween ttumour yield ani(l
age at initiationi foi animals piromote(l at
71 86 weeks of age (from Appendix Tables
(I aii(I e). Symhbols as in Fig. 2.
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FIG. f. T'lurimotur response: O/E x-alties givilng
relationships between tumour yield an(l age
at iruitiatiomi for animals whlic(hi w\ere all
promotedl at 51-66 wveeks of age (fiorn
Appen(lix Tables (I and( e). Symbols as ill
Fig. 2.
effect of TPA does decrease somewhat as
the mice get past 1 year of age and on to
the age of 18 months or so. Finally, we
have inferred that if IDMBA is given only
3 weeks before TPA, we get a greater
tumour yield than if it had been much
earlier. If these hypotheses are indeed
correct, we should find no material
dependence of tumour rates on time since
initiation, except for an excess rate among
those initiated just previously.
Figs 4 and 5 summarize the relevant
comparisons between animals promoted
at a fixed age (which eliminates all arte-
facts due to the age-dependence of pro-
motion). Fig. 5 does show the expected
increase in effect when initiation is just
before promotion, buit Fig. 4 does not.*
Among our many comparisons, this is the
only result which is not concordant with
our hypotheses. Moreover, since the pre-
dicted increase in tumour yield when
initiation jtust precedes promotion is
clearly seen in Fig. 5, the lack of it in
Fig. 4 is not strong evidence against our
general concluision that promotion rather
than initiation varies with age, especially
since the direction of the
not indicate any loss of
with time.
ainomaly dloes
initiated cells
D)ISCUISSION
WVe have found that both animilals
initiated early in life and promoted late
in life and those initiated and promoted
late yield only about half the tumours of
animals initiated and promoted early.
These findings may be explained in 2
main ways:
(a) "Single" hypothesis: promotioin late
in life is less effective than promotion
early in life, ancd
(b) "Double" hypothesis: initiation late
in life is less effective than initiation early
in life, and among animals initiated early
in life there is a substantial loss ofinitiated
cells between ages 12 and 18 months.
Logically, it is clear that there can be
no wavy, from experiments such as oturs,
ofdistinguishing between the "single" and
the "double" hypotheses above. However,
the "double" hypothesis requires the
existence of 2 separate mechanisms which
by chance yield similar quantitative
* This may merely refleet te fact tbat there were almost nio high-(lose survivors left at 80 vWeeks in
Grouip e for comparison with tile high-dose mice in Group hi, wliich meanis that the few survivors in Group e
are rather select and that the O/E ratio in tlihe larger grouip is biasedt towsaids unit.v.
;si-- - :
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effects. We therefore consider the "single"
hypothesis, that there is a decrease in the
efficacy of promotion as animals age, to
be a more economical, and hence more
plausible, explanation for our findings.
Supporting evidence for it could perhaps
be obtained by studying the biochemical
or histological response of young adult
and of very old adult mouse skin to TPA
(for details and references, see Stenback
et al., 1981a). TPA is known to induce
enormous increases in certainenzymessuch
as ornithine decarboxylase and plasmino-
gen activator, as well as in "primitive stem
cells" (or "dark" cells). If the inducibility
of cells from old skin was found to be less,
this would strengthen our hypothesis.
Conversely, it is now possible to measure
the numbers of polyaromatic hydrocarbon
molecules bound per 106 DNA bases in
the epithelial basal layer after initiation,
and it might be useful to study the age-
dependence of this binding. Doses lower
than those we have studied should prob-
ably be studied, as the flat dose-response
relationship we have observed (Stenback
et al., 1981ib) suggests that we are saturat-
ing the target cells. Our data therefore
provide no direct evidence of the rever-
sibility of initiation to be expected if
non-saturating doses (perhaps of - 0- jug
DMBA in 1/60 ml acetone, or 1 ,ug
DMBA in 0-2 ml acetone) were used for
initiation.
In 1949, Berenblum & Shubik concluded
that initiation was irreversible and that
initiated cells persisted in the skin. Their
evidence for this was comparison of 2
experiments in which there was the same
apparent effect of promotion at 3 as at 43
weeks after initiation. The findings of Roe
et al. (1972), van Duuren et al. (1978) and
the present study show conclusively that
Berenblum & Shubik's quantitative find-
ings were not reproducible, but the present
study suggests that their conclusion was
substantially correct, at least to within a
factor of 2.
Initiation is probably more or less
irreversible, and the effects of initiation
with subtumorigenic doses of DMBA are
probably more or less independent of age.
However, (i) the efficacy of promoters
appears to decrease in ageing mice, (ii)
if DMBA doses large enough to kill skin
cells are given the promotional effects of
the resultant healing processes are greater
in older than in younger mice, and (iii)
if promotion is administered before the
skin has been given a chance to settle
down again after initiation, the tumour
yield will be greater.
These conclusions explain naturally
why it was that, when Peto et al. (1975)
tested on mouse skin the carcinogenicity
of repeated subtoxic doses of benzo(a)
pyrene (a chemical which resembles
DMBA much more than TPA in its likely
mode of action) they found, after correct-
ing by life-table methods for intercurrent
mortality, that the neoplastic response
was independent of the age (10, 25, 40, or
55 weeks) at which treatment began. It
appears to be the promotional, rather than
the initiating, processes which vary with
age, and which account for most or all of
the anomalies which we and others have
observed.
Whether analogous promnotional pro-
cesses govern human tumour induction is
not known. It should be emphasized that
although the little papillomas that can be
elicited rapidly by TPA have been referred
to as "tumours", both by us and by many
others who have studied initiation and
promotion on mouse skin, their biological
nature is very different from that of an
invasive carcinoma. In particular, many
of them are not autonomous and may
either shrink or disappear completely
when regular treatment with TPA ceases
(or even, in some instances, while it con-
tinues). There is obviously no necessary
analogy between the aetiologies of such
lesions and of invasive carcinomas. But
we note that, in our analyses where there
were a sufficient number of carcinomas for
statistical stability, the observed effects
of the various delays of initiation and pro-
motion on invasive carcinomas have
generally been rather similar to the effects
on papillomas.
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APPENDIX
TABLE a.-Response to promotion
1. The cited percentages are basedl upon the animals which were free of all tumours when promotion
started. Each percentage is a life-table estimate of the proportion that would have developed one or more
tumours within 20 weeks of starting promotion.
2. The entry "T/M = x + y in a/b/c" indicates that c animals underwent initiation, b survived to the start
of promotion, and a of these survived a further 20 weeks thereafter, and that among these 20-week survivors
an average of x new tumours per mouse arose during the 20 weeks after the start of promotion. y is an
estimate of the standard error of x. Overall, 2200 mice were initiated, 1701 started promotion and 1082
were alive 20 weeks thereafter.
3. Finally, the crop of new tumours elicited within 20 weeks of the start of promotion is further character-
ized by listing in brackets, for eaclh new tumour-bearing survivor 20 weeks after starting promotion, the
number of new tumours that arose since promotion began. ("3 x 1, 2" means 3 animals had one each and one
animal had 2, etc.)
300 ,ug
initiation
69%
T/M = 2-00 + 0-27
in 73/80/80 (19 x 1,
9 x 2, 9 x 3, 6 x 4,
5 x 5, 6, 6, 7, 14)
100 fg
initiation
62%
T/M= 1-44+0-29
in 34/40/40 (9 x 1,
7 x 2,3 x 3,4,6,7)
30 ,ug
initiation
26%
T/M = 0-66 + 0-24
in 38/39/40 (4 x 1,
3 x 2,3,6,6)
10 pg
intiation
33%
T/M = 0-64 + 0-18
in 39/40/40 (6 x 1,
4x 2, 3,4,4)
b 8 18-33
c 8 31-46
d 8 51-66
e 8 71-86
f 48 51-66
g 48 71-86
hI 68 71-86
64% 25%
T/M= 1-25+ 0-20 T/M= 0-58 + 0-19
in 51/79/80 (19 x 1, in 33/40/40 (4 x 1,
4x 2, 6x 3,4,4,5, 6) 2, 3x 3,4)
46%
T/M=0-79+0-15
in 34/69/80 (10 x 1,
7 x 2, 3)
59%
T/M = 1-50 + 0-63
in 8/31/60 (1, 1, 2,
3,5)
0/1(/80
No surviv-ors at
W'eek 91
59%
T/M= 1-37 + 0-21
in 40/59/60 (7 x 1,
10 x 2, 4 x 3, 4 x 4)
53%
T/M = 0-82 + 3-8
in 11/55/80(3 xl,
2,4)
61%
T/M = 1-00 + 0-21
in 30/78/80 (13 x 1,
4 x 2,4,5)
32%
T/M = 0-44 + 0-16
in 25/37/40 (4 x 1,
2,2,3)
420o
T/M=0-64+ 0-18
in 28/44/60 (6 x 1,
3 x 2, 3, 3)
52%
T/M = 0-63 + 0-18
in 19/41/80 (6 x 1,
3 x 2)
630°
T/M= 1-05 + 0-20
in 37/58j60 (15 x 1,
6 x 2, 2 x 3, 6)
29%
T/M = 0-68 + 0-24
in 25/59/80 (5 x 1,
2, 2, 3, 5)
34%
T/M=0-47+0-11
in 38/78/80 (14 x 1,
9 x 2)
39%
T/A= 1-16+0-32
in 38/39/40 (3 x 1,
6 x 2, 3 x 3, 5, 6, 9)
22%
T/M=0-56+0-25
in 32/37/40 (2 x 1,
3,7)
34%
T/M=0-64+ 0.16
in 33/52/60 (7 x 1,
4 x 2, 2 x 3)
8%
T/M=0-16+ 012
in 25/47/80 (1, 3)
46%
T/M= 1-00+0-20
in 47/59/60 (10 x 1,
8x 2, 3, 3, 4, 5, 6)
31%
T/M=0-36+0-12
in 36j63/80 (6 x 1,
2, 2, 3)
21%
T/M=0-74+0-33
in 38/77/80 (6 x 1,
3 x 2,4, 12)
18%
T/M = 0-24+ 0-09
in 38/40/40 (5 x 1,
2,2)
50%
T/M=0-80+0-17
in 35/39/40 (10 x 1,
3 x 2, 4 x 3)
27%
T/M=0-22+0-07
in 41/56/60
(7 x 1,2)
8%
T/M =0-03 + 0-03
in 32/61/80 (1)
40%
T/M=0-63+0-16
in 52/56/60 (13 x 1,
5 x 2, 4, 6)
15°/
T/M=0-22+0-13
in 36/68/80
(1, 1, 2, 4)
10%
T/M=0-14±+0-07
in 36/70/80
(3 x 1,2)
40 animals per dose-level initiated but not promoted.
Age at
initia-
tion
(wks)
8
Proto-
col
a
Ages
during
promo-
tion
(wks)
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TABLE d.-The effects of age at initiation on total tumour yields within 20 weeks ofstarting
promotion, promotion being at afixed age
Total numbers of tumours (including second and subsequent tumours) during the 20 weeks from the start
ofpromotion, among animals promoted at a fixed age (51-66 or 71-86 weeks, as indicated) following initiation
at various previous ages, excluding animals which died less than 20 weeks after starting promotion.
Abbreviations andl footnotet as in Appendix Table b.
Age at DMBA Age at DMBA
8 weeks 48 weeks
Ageat,
promotion S 0 E S 0 E
51-66 8 12 11-2 40 55 55-8
71-86 0 0 0*0 11 9 10-5
51-66 28 18 24-6 37 39 32-4
71-86 19 12 10-9 25 17 14-3
51-66 33 21 28-0 47 47 40-0
71-86 25 4 11-4 36 13 16-3
51-66 41 9 18-5 52 33 23-5
71-86 32 1 4-3 36 8 4-9
51-66 110 60 82-3 176 174 151-7
71-86 76 17 26-6 108 47 46-0
51-66 O/E=0 73 O/E=1-15
71-86 O/E =0-64 O/E = 1-02
Age at DMBA Total
68 weeks (all ages)
S O E S O E
48 67 67-0
30 30 28-5 41 39 390
65 57 57 0
38 18 21-8 82 47 47 0
80 68 68-0
38 28 17-3 99 45 45 0
93 42 42-0
36 5 4-8 104 14 14-0
286 234 234-0
142 81 72-4 326 145 145-0
1-00 necessarily
O/E = 1-12 1-00 necessarily
APPENDIX TABLE e.-The effects of age at initiation on first tumour yields at any time
following promotion, promotion being at afixed age
Type of DMIBA
lesions dose
counted (,g)
(ii) any 300
tumours 300
(ii) any 100
tumours 100
(ii) aiiy 30
tumours 30
(ii) any 10
tumours 10
(ii) any all* doses
tumours
Total 0-
total E
(iii) 10 mm all* doses
tumours
Total 0÷
total E
(iv) Malig- all* (loses
nancy
Total 0÷
total E
Age at DMBA Age at DMBA Age at DMBA
8 weeks 48 weeks 68 weeks
Age at ,
promotion N 0
51-66
71-86
51-66
71-86
51-66
71-86
51-66
71-86
51-66
71-86
51-66
71-86
51-66
71-86
51 -66
71-86
51-66
71-86
51-66
71-86
E
21 7 11-3
8 0 1-1
32 14 18-3
36 14 8-5
52 16 19-7
46 3 8-4
56 17 20-2
60 6 5-9
161 54 69-6
150 23 23-9
O/E = 0-78
O/E = 0-96
182 12 17-5
159 9 6-4
O/E = 0-69
O/E = 1-40
180 7 10-9
157 2 1-6
O/E = 0-64
O/E = 1-27
N O E
58 32 27-7
24 7 9-6
58 32 27-7
50 10 13-8
59 26 22-3
58 15 9-0
56 23 19-8
67 9 6-8
231 113 97.4
199 41 39-1
O/E= 1-16
O/E = 1-05
231 33 27-5
232 15 13-4
O/E = 1-20
O/E = 1-12
232 26 22 1
242 8 4-4
O/E = 1-18
O/E= 1-81
N O E
78 32
72 17
77 12
70 5
28-3
18-7
12-6
7-4
297 66 67-0
O/E = 0.99
303 11 15-2
O/E=0-72
303 3 7 0
O/E = 0 43
Total
(all ages)
N O E
79 39 390
110 39 39 0
90 46 46-0
158 41 41-0
111 42 42-0
181 30 30 0
112 40 40 0
197 20 20-0
392 167 167-0
646 130 130-0
P= 0-01
P=09
413 45 450
694 35 35 0
P=0-1
P=0-1
412 33 330
702 13 13-0
P=0-1
P=0-1
* See footnote to Appendix Table c.
DMBA
dose
300 jig
300 jug
100 ,ug
100 ,ug
30 pg
30 ,ug
10 jug
10 pg
Totals
(4 (loses)
Total 0-.
total Et